BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37429610)

  • 21. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
    Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
    Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer.
    Li Q; Liu J; Jia Y; Li T; Zhang M
    Aging (Albany NY); 2020 Jun; 12(11):10246-10258. PubMed ID: 32501811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
    Xu Y; Ren Z; Wang X; Ren M
    J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2.
    Zhou Z; Yang P; Zhang B; Yao M; Jia Y; Li N; Liu H; Bai H; Gong X
    Pharmacology; 2021; 106(11-12):573-587. PubMed ID: 34488224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HAND2-AS1 Works as a ceRNA of miR-3118 to Suppress Proliferation and Migration in Breast Cancer by Upregulating PHLPP2.
    Dong G; Wang X; Jia Y; Jia Y; Zhao W; Zhang J; Tong Z
    Biomed Res Int; 2020; 2020():8124570. PubMed ID: 33015182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
    He S; Wang X; Zhang J; Zhou F; Li L; Han X
    Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
    Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
    Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
    [No Abstract]   [Full Text] [Related]  

  • 29. EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
    Shuang O; Zhou J; Cai Z; Liao L; Wang Y; Wang W; Xu M
    J Orthop Surg Res; 2022 Jun; 17(1):332. PubMed ID: 35761386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA PGM5-AS1 Inhibits the Progression of Bladder Cancer by Regulating miR-587/SLIT3 Axis.
    Duan X; Wang L; Wang Z; Wei W; Wang M; Ding D
    Crit Rev Eukaryot Gene Expr; 2022; 32(8):9-22. PubMed ID: 36017912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1.
    Zhou M; Bian Z; Liu B; Zhang Y; Cao Y; Cui K; Sun S; Li J; Zhang J; Wang X; Li C; Yao S; Yin Y; Fei B; Huang Z
    Cancer Med; 2021 Apr; 10(7):2470-2481. PubMed ID: 33686713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
    Zhang M; Xu Y; Yin S; Qiu F
    Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
    Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
    Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
    [No Abstract]   [Full Text] [Related]  

  • 36. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.
    Fang C; Xu L; He W; Dai J; Sun F
    Cell Cycle; 2019 Dec; 18(23):3288-3299. PubMed ID: 31615303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
    Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
    J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.